FAQ about this common recommendation.
What's New
How do providers decide which people will benefit from chemotherapy with stage II colon cancer?
Darolutamide (Nubeqa®) is an androgen receptor inhibitor used in the treatment of patients with non-metastatic, castration-resistant prostate cancer.
Rituximab-pvvr (Ruxience™) is a biosimilar monoclonal antibody used in the treatment of some types of leukemias and lymphomas.
OncoLink Apps
Blogs
OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
View all Blogs
Cancer Awareness
Summer Sun Safety Month
It’s summertime - that means fun, sun and vacations! Just because you are going through cancer treatment doesn’t mean you can’t take a vacation. Watch the Cancer Goes to the Beach webinar to get tips and resources to plan a safe and stress free getaway. July is also UV Safety Month – learn all you need to know to stay sun safe this summer.
Need Cancer Patient Education Tools?
Our award winning cancer education content is now available for licensing and syndication.
I Wish U Knew!
I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.